Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - 18(2023), 6 vom: 01. Juni, Seite 785-787 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Teisseyre, Maxime [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 12.06.2023 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2215/CJN.0000000000000152 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354483463 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354483463 | ||
| 003 | DE-627 | ||
| 005 | 20240411232033.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.0000000000000152 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1372.xml |
| 035 | |a (DE-627)NLM354483463 | ||
| 035 | |a (NLM)36942995 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Teisseyre, Maxime |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.06.2023 | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 650 | 7 | |a Receptors, Phospholipase A2 |2 NLM | |
| 700 | 1 | |a Brglez, Vesna |e verfasserin |4 aut | |
| 700 | 1 | |a Cremoni, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandez, Céline |e verfasserin |4 aut | |
| 700 | 1 | |a Graça, Daisy |e verfasserin |4 aut | |
| 700 | 1 | |a Boyer-Suavet, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Benzaken, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Esnault, Vincent L M |e verfasserin |4 aut | |
| 700 | 1 | |a Seitz-Polski, Barbara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g 18(2023), 6 vom: 01. Juni, Seite 785-787 |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:6 |g day:01 |g month:06 |g pages:785-787 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.0000000000000152 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 6 |b 01 |c 06 |h 785-787 | ||